Skip to main content


Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: Metabolic reprogramming: the emerging concept and associated therapeutic strategies

Fig. 2

Tumor heterogeneity in metabolism. The degree of addiction to glucose or glutamate differs among various types of cancer cells. Tumor cells robustly importing glucose via the GLUT1 transporter are responsible for the high intensity of FDG-PET in the clinical settings. Cancer cells that express high levels of GLUT1 also induce a low-pH acidic tumor microenvironment, thereby increasing the invasive potential of tumors

Back to article page